March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Fibre optics and optical communications is the use of thin strands of glass for sending information encoded into light over long distances. Total internal reflection prevents light inserted into ...

MERK has already: With one of the Must-Watch Crypto Presales of 2025 launching on March 17, early participants gain access to staking rewards before the token becomes publicly tradable.

SOFIA, BULGARIA, March 10th, 2025, Memecoins have demonstrated the potential for online culture and blockchain technology to converge, creating blockchain-based ...

After hours: March 14 at 7:59:38 PM EDT Loading Chart for MRK ...